Merrill Corporation in partnership with BioCentury presents the 1Q16 Financial Markets Preview report which provides a review of all biotech activity in the final quarter of 2015.
The report provides useful insight to help plan for financial endeavors in Q1 2016 and uncovers some interesting statistics:
- Biotech’s 2015 performance was on pace to match 2014 until the sector lost 23% in 3Q15.
- In 4Q, 19 companies raised $1.2 billion in IPOs. For the full year, 83 companies raised $8 billion, which was the third largest annual amount raised since 1994, when BioCentury started tracking industry financings.
- The 2015 class of follow-ons ended the year down a median of 15% from their postmoney valuations. 4Q follow-ons were off a median of 3%.